We demonstrated that BARX1 was upregulated and functioned as an oncogene, whereas ZFP36 was downregulated and acted as a suppressor in NSCLC cell lines and clinical tumor tissues. The gene discussed is BARX1; the disease is non-small cell lung carcinoma.